PFIZER PROCARDIA XL SALES ARE $40 MIL. IN FIRST THREE MONTHS ON MARKET; GENENTECH ACTIVASE REVENUES JUMP 63% IN FOURTH QUARTER TO $56.7 MIL.

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".